Adams Respiratory Therapeutics Inc

Adams Respiratory Therapeutics — Investor Presentation (October 2006)

26 slides from Adams Respiratory Therapeutics's investor presentation, Oct 19, 2006

  1. Slide 1: Investor Presentation October 19, 2006

    Slide 1: Investor Presentation October 19, 2006

    Investor Presentation October 19, 2006

  2. Slide 2: Safe Harbor

    Slide 2: Safe Harbor

    Safe Harbor This presentation contains certain "forward-looking" statements. These statements are based on the current estimates and assumptions of the management of Adams Respiratory Therapeutics, Inc. (or "Adams") as of the date of this presentation and are naturally subject to uncertainty and cha

  3. Slide 3: Began Fiscal 2006 and 2007 With: More Products Recently Launched

    Slide 3: Began Fiscal 2006 and 2007 With: More Products Recently Launched

    Began Fiscal 2006 With: Began Fiscal 2007 With: Fiscal 2007: More Products Recently Launched:

  4. Slide 4: 2006-2007 Cough/Cold/Flu Season Early Indicators

    Slide 4: 2006-2007 Cough/Cold/Flu Season Early Indicators

    2006-2007 Cough/Cold/Flu Season Early Indicators Source: Surveillance Data Inc. U.S. National Report tracking respiratory illness for 4 weeks ended 10-13-06. Population Typical Start of Peak Season 0 5,000,000 10,000,000 15,000,000 20,000,000 25,000,000 30,000,000 35,000,000 40,000,000 45,000,000 50

  5. Slide 5: Consumer Survey Supports Growth Opportunities

    Slide 5: Consumer Survey Supports Growth Opportunities

    Consumer Survey Supports Growth Opportunities Product Usage: Last Season vs. Now Product Usage: Last Season vs. Now Product Usage: Last Season vs. Now Product Usage: Last Season vs. Now Product Usage: Last Season vs. Now 6/17/06 10/01/06(2) 10/01/06(2) Opportunity Mucinex(r) 18%(1) 18%(1) 23% Contin

  6. Slide 6: Mucinex Total Brand Awareness Current Season vs. Last Season

    Slide 6: Mucinex Total Brand Awareness Current Season vs. Last Season

    Mucinex(r) Total Brand Awareness Current Season vs. Last Season Source: Company sponsored research.

  7. Slide 7: ACV Distribution - IRI Trend Report

    Slide 7: ACV Distribution - IRI Trend Report

    ACV Distribution - IRI Trend Report Mucinex Products (SE,DM,D, Cough Syrup) Point change VYA 0 20 40 60 Drug Food F/D/Mx Mucinex(r) D Mucinex(r) DM Mucinex(r) SE

  8. Slide 8: Solid Brand Ranking

    Slide 8: Solid Brand Ranking

    Solid Brand Ranking Food/Drug/Mass Food/Drug/Mass Food/Drug/Mass Rank Brand Sales 1 Benadryl Tablets $10,864,827 2 Claritin $9,912,266 3 Claritin D $9,739,961 4 Mucinex(r) $6,203,735 5 Sudafed PE $5,500,902 6 Vicks Nyquil $5,049,549 7 Airborne $4,041,496 8 Alavert $3,655,661 9 Mucinex(r) DM $3,539,8

  9. Slide 9: Adams Products in Drug Channel

    Slide 9: Adams Products in Drug Channel

    Adams Products in Drug Channel Examples of End-Cap Displays Aisle

  10. Slide 10: Adams Products in Food Channel

    Slide 10: Adams Products in Food Channel

    Adams Products in Food Channel

  11. Slide 11: Adams Products in Club Store Channel

    Slide 11: Adams Products in Club Store Channel

    Adams Products in Club Store Channel

  12. Slide 12: Advertising Drives Mucinex Unit Volume

    Slide 12: Advertising Drives Mucinex Unit Volume

    03/19/06 Advertising Drives Mucinex(r) Unit Volume Historical Retail Consumption - Total Brand (20 ct equiv.) Source: Industry data week ending 3/19/06 04/05 Season 05/06 Season Growth in awareness is driving significant expansion of the brand Mr. Mucus(r) campaign first airs 11/15/04 "Married to Mu

  13. Slide 13: Advertising Drives Mucinex Unit Volume

    Slide 13: Advertising Drives Mucinex Unit Volume

    Advertising Drives Mucinex Unit Volume Retail Consumption - Total Brand (20 ct equiv.) 05/06 Season 06/07 Season "Married to Mucus" campaign first airs 10/27/05

  14. Slide 14: Bob Casale, Executive Vice President, Chief Marketing and Development Officer

    Slide 14: Bob Casale, Executive Vice President, Chief Marketing and Development Officer

    Bob Casale Executive Vice President Chief Marketing and Development Officer

  15. Slide 15: Mucinex Core Equity

    Slide 15: Mucinex Core Equity

    Mucinex(r) Core Equity Core Equity Positioning Mucinex(r) Mucus out Chest congestion Mucinex(r) D Mucus out Nasal congestion Mucinex(r) DM Mucus out Nighttime cough

  16. Slide 16: Mucinex Commercial

    Slide 16: Mucinex Commercial

    ..15 Mucinex(r) Commercial

  17. Slide 17: Mucinex DM Commercial

    Slide 17: Mucinex DM Commercial

    ..30 Mucinex(r) DM Commercial

  18. Slide 18: Mucinex Mini-Melts Core Equity

    Slide 18: Mucinex Mini-Melts Core Equity

    Mucinex(r) Mini-Melts(tm) Core Equity Core Equity Positioning Mucinex(r) Mini-Melts(tm) Mucus out Kids' chest congestion and compliance

  19. Slide 19: Mucinex Mini-Melts Commercial

    Slide 19: Mucinex Mini-Melts Commercial

    ..30 Mucinex(r) Mini-Melts(tm) Commercial

  20. Slide 20: Delsym Core Equity

    Slide 20: Delsym Core Equity

    Delsym(r) Core Equity Core Equity Positioning Delsym(r) 12-hour cough suppression Controls the urge to cough all day or all night

  21. Slide 21: Delsym Mini-Melts Commercial

    Slide 21: Delsym Mini-Melts Commercial

    ..30 Delsym(r) Mini-Melts(tm) Commercial

  22. Slide 22: Mucinex and Delsym Primetime Advertising Highlights

    Slide 22: Mucinex and Delsym Primetime Advertising Highlights

    Mucinex(r) and Delsym(r) Primetime Advertising Highlights Children's Mucinex(r) Mini-Melts(tm) begins Oct. 17: ABC Boston Legal ^ FOX House NBC Friday Night Lights ^ FOX Justice CBS CSI Delsym(r) begins Oct. 23: CBS Two and a Half Men ^ ABC Dancing with the Stars ABC The Nine ^ CBS Survivor ABC Wife

  23. Slide 23: Heavy Professional Promotion

    Slide 23: Heavy Professional Promotion

    Mucinex(r) Adult Family Over 21/2 million impressions to the professional audience (2,551,500) ^ American Family Physician ^ Family Practice News ^ Journal of Respiratory Disease ^ Medical Economics ^ Nurse Practitioner ^ Journal of the American Academy of Physician Assistants ^ Journal of Allergy a

  24. Slide 24: DC Comics Teams with Mr. Mucus & Family

    Slide 24: DC Comics Teams with Mr. Mucus & Family

    DC Comics Teams with Mr. Mucus(r) & Family DC Comics is a registered trademark of Warner Bros. Entertainment.

  25. Slide 25: Adams' Business Strategy

    Slide 25: Adams' Business Strategy

    Adams' Business Strategy Build internal pipeline by extending guaifenesin platform to other OTC & Rx respiratory segments Access platform technologies to accelerate product development Four - pronged strategy Drive Mucinex(r) brand awareness & market share among professionals and consumers Build Rx

  26. Slide 26: Investor Presentation October 19, 2006

    Slide 26: Investor Presentation October 19, 2006

    Investor Presentation October 19, 2006

Source: SEC EDGAR · 8-K filed Oct 19, 2006

More decks from Adams Respiratory Therapeutics Inc